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Introduction: In children with disabilities, precocious puberty (PP) has been reported,
however there is a paucity of studies on delayed puberty (DP) in neurologically impaired
(NI) children.
Patients andMethods: We retrospectively evaluated 65 patients with severe disabilities
(6–18 years). DP was considered whenever the following criteria where satisfied,
respectively, for girls and boys, absence of breast development by age 13 or menarche
by age 15, absence of at least 4mL testicular growth volume or 2.5 cm length by age 14.
PP was defined as the presence of puberty signs at <8 and 9 years of age, respectively,
for girls and boys. In all patients, a physical examination was performed and a family
history of DP was obtained. A hormonal panel was evaluated when puberty disorders
were detected. As a control group we evaluated 50 age-matched healthy subjects.
Results: Puberty disorders were observed in 12 NI patients and in one control (18.5
vs. 2%, p < 0.01). DP was detected in 8 NI subjects (3M/5F) and in one healthy boy
(p = 0.04), without differences between genders among patients from the NI group
(p = 0.2), and compared with the controls (p = 0.4). In five of the eight NI subjects,
Tanner stage 1 was observed; in three subjects adrenarche was present without pubertal
progression for more than 2 years. Low levels of gonadotropins were detected in all NI
subjects with DP. The number of subjects with a BMI <-3SDS was higher in NI patients
with DP compared to NI subjects with normal puberty (p < 0.01); normal weight was
detected in one healthy boy. The family history for pubertal delay was negative in all NI
patients with DP and positive in the control subject.
Conclusion: NI children and adolescents may experience delayed pubertal
changes. An endocrinological follow-up with pubertal development monitoring is
strongly recommended in order to evaluate whether targeted interventions may
improve outcomes.
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INTRODUCTION
Puberty is a physiologic process marked by the appearance
of secondary sex characteristics (1). The absence of sexual
maturation signs at 2–2.5 standard deviations or more than the
mean age (ca. 13 year in girls and 14 year in boys) was defined as
Delayed Puberty (DP) (2).
In children and adolescents with disabilities, the pattern of
sexual maturation may differ from that of children in the general
population (3) with possible abnormal puberty development.
Brain injury during structural and functional brain maturation
in the pre-, peri-, or post-natal period may negatively impact the
development of pubertal changes (4).
Sexual maturation may also be delayed; (3, 5) moreover,
there is a paucity of studies on pubertal delay in neurologically
impaired (NI) children. For this reason, in this report, we
focused our attention on the occurrence of DP in NI children
and adolescents in order to define the need for appropriate
surveillance to prevent adverse effects related to delayed
pubertal timing.
PATIENTS AND METHODS
Patients
We retrospectively evaluated 65 patients (37M/28F) with severe
disabilities aged 6–18 years (mean age 13.5 ± 0.4 years), referred
to our Endocrinological Unit for auxological evaluation or
Pediatric Surgical Unit for treatment and/or management of
nutrition support. All of the patients, were bedridden, whether
they lived at home or in sheltered communities. Diagnoses
included cerebral palsy due to hypoxic ischemic damage (44%),
severe psychomotor delay in dysmorphic syndromes without
a clear association with pubertal disorders (30%), epileptic
encephalopathy (26%). Anticonvulsive drugs (at least two of the
following: phenobarbital, valproic acid, phentoyn, lamotrigine,
topiramate, carbamazepine, and clonazepam) were reported in
58/65 of the patients (89.2%).
As a control group we evaluated 50 age-matched healthy
subjects (21F/29M; mean age 12.0 ± 0.5 years) referred by
their general practitioner or primary care pediatrician to our
Outpatient Clinic for auxological evaluation. The study was
approved by the Fondazione IRCCS Policlinico San Matteo
Institutional Review Board and according to the 1964Declaration
of Helsinki. After receiving information on the nature of the
study, written informed consent was obtained from the parents
of the participating children.
Methods
All patients underwent a physical examination including: weight,
height, body segment measurements, as previously described
(6). Body Mass Index (BMI) was calculated by dividing the
patient’s weight in kilograms by the square of the height in meters
and the BMI Z-score (standard deviation), was calculated using
UptoDate calculators based on the Centers for Disease Control
and Prevention growth charts (7, 8).
Pubertal development was classified according to Marshall
and Tanner (9, 10) and the population was classified as stage
one corresponding to Tanner 1; stage 2 corresponding to Tanner
2–3; and stage 3 corresponding to Tanner 4–5. The absence of
breast development by age 13 or menarche by age 15, absence
of at least 4mL testicular growth volume, or 2.5 cm length by
age 14 were considered delayed puberty (DP), respectively, for
girls and boys (2, 9, 10). Precocious puberty was defined as the
presence of puberty signs before 8 and 9 years of age, respectively,
for girls and boys (9, 10). An extended family history of pubertal
delay was recorded and patients were classified as having at
least a familiar tendency to DP (men with pubertal onset >13
years and/or growth spurt >15 years; women with menarche
>14 years) or diagnosed with DP (men with pubertal onset >14
years and/or growth spurt>16 years; womenwithmenarche>15
years) (2). Gonadotropin levels were evaluated when disorders
of puberty were detected and LH, FSH were measured with a
chemiluminescent immunometric assay.
Statistical Analysis
Continuous variables are presented as the mean ± standard
deviation; categorical variables are expressed as numbers or
percentage of patients. The statistical significance of the
continuous variable comparisons was assessed using the unpaired
Student’s t-test; the comparison of categorical variables was
conducted using the chi square test or Fisher’s Exact test if
there was a small (<5) expected cell size. Stata 15.1 (StataCorp,
College Station, Tex., USA) was used for computation. All
statistical tests were two-tailed and a p < 0.05 was considered
statistically significant.
RESULTS
The clinical features of the NI subjects are reported in Table 1.
The average age of the disabled children at evaluation was 12.7
± 4.2 years for males and 14.6 ± 3.4 years for females, without
significant differences with the controls (p= 0.09).
Puberty disorders were observed in 12 NI patients and in one
control (18.5 vs. 2%, p < 0.01). DP was detected in 8 NI subjects
(three males and five females, Table 1) and in one healthy boy
(p = 0.04), without differences between genders among patients
from the NI group (p = 0.2), and compared with the controls
(p = 0.4). In four NI patients (6.1%), PP was also detected (two
central precocious, treated with GnRH analog and 2 premature
adrenarche not treated).
The average age of the NI subjects diagnosed with DP was
12.6 ± 4.4 years for males and 13.9 ± 2.7 years for females. As
reported in Table 1, in five of the eight NI subjects, Tanner stage
1 was observed (mean age 13.8 ± 3.8 years); in three subjects
adrenarche was present (three patients with PH 2 and 1 with
PH3) without pubertal progression for more than 2 years.
Low levels of gonadotropins were detected in all NI subjects
with DP (Girls: LH 0.7 ± 0.5 IU/liter; FSH 1.4 ± 1.2 IU/liter.
Boys: LH 0.4 ± 0.3 IU/liter; FSH 0.8 ± 1.0 IU/liter). Magnetic
resonance imaging was performed in only one patient with DP;
no hypothalamic-pituitary malformations were observed.
The number of subjects with a BMI <-3SDS (severely
underweight) (11, 12), was higher in NI patients with DP
compared to NI subjects with normal puberty (p < 0.01);
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TABLE 1 | Clinical features of the NI subjects.
All NI
subjects
(n = 65)
NI subjects
with DP
(n = 8)
NI subjects
without DP
(n = 57)
p*
Sex (M/F) 37/28 3/5 34/23 0.2
Age at evaluation 13.5 ± 4.0 14.9 ± 2.6 15.0 ± 3.7 0.9
Diagnosis
– Hypoxic ischemic damage 28 4 24
– Epileptic encephalopathy 20 1 19 0.5
– Dysmorphic syndromes 17 3 14
Pubertal stages
– Tanner 1 18 5 13
– Tanner 2-3 15 3 12 <0.01
– Tanner 4-5 32 0 32
Nutritional support
– Enteral feeding 60 7 53 0.6
– Oral feeding 5 1 4
Anticovulsivant drug 58 7 51 0.8
Severe malnutrition (BMI<-3SDS) 23 6 17 <0.01
Family history of pubertal delay 1 0 1 0.3
*NI subjects with DP vs. NI subjects without DP.
no association between DP and type of nutritional support
(p= 0.6) was noted, Table 1. Normal weight was detected in one
healthy boy.
Seven NI patients diagnosed with DPwere treated with at least
two anticonvulsive drugs (p= 0.8, Table 1).
The family history for pubertal delay was negative in all NI
patients with DP (Table 1) and positive in the control subject.
DISCUSSION
Puberty onset for individuals living in relatively similar
conditions, is characterized by a 4–5 years physiological variation
in sexual maturation (1–3), and is expected to occur between
8–13 and 9–14 years of age, respectively, in girls and boys (2).
NI children could experience disorders of puberty in term
of precocious or delayed puberty. Pediatric patients affected by
neurodevelopmental disabilities are 20 times more at risk of
premature pubertal changes compared to the general population
(4). Many insults to the central nervous system including
birth asphyxia, congenital malformation and infections can
cause PP (4). Severe brain damage and use of antiepileptic
medication may affect a number of neurotransmitter pathways
involved in gonadotropin control, inducing an activation
of the hypothalamic-pituitary-gonadal axis (13). Additionally,
precocious sexual development has been described in several
genetic disorders and malformative syndromes with midline
brain involvement (4).
In this brief report, we documented a high occurrence of DP in
NI children and adolescents, without differences between genders
and in the absence of a family history.
The etiology of delayed puberty in NI patients may be
multifactorial (1, 2, 14), but in our small study population
a causative factor was not identified. However, it is known
that secondary chronic malnutrition reported in these patients
(6) largely contributes to their delayed initiation of pubertal
development. Nutrition and nutritional status impact pubertal
development (9), and are responsible for up to 25% of the changes
in puberty timing. Adolescent sexual development, both in boys
and girls, is affected by chronic malnutrition during childhood
(14). NI patients suffering from secondary malnutrition (6) may
also suffer delayed puberty onset.
Despite BMI is not a reliable indicator of nutritional status
and it may not have an etiological role in pubertal disorders (4),
in this pediatric population severe undernutrition is associated
with body composition disturbances (15). Undernutrition and
low body fat mass, or an altered ratio of lean mass to body fat,
seem to play a crucial role in the initiation of puberty (16).
Other explanations for puberty delay may be associated
with cumulative stress (17) frequently reported in this
fragile population; metabolic and physiologic stress activate
hypothalamic-pituitary-adrenal axis and suppress hypothalamic-
pituitary-gonadal axis (18). Additionally the use of medications
could influence the levels of different sex hormones resulting in
effects on the pubertal development (4).
Brain malformation associated with pituitary dysfunction can
also be considered (19). However, the role of genetic factors and
fetal programming should not be excluded (1–3).
Although not always acknowledged, self-limiting DP is not
totally benign and could be related to an increased risk for
metabolic and cardiovascular disorders, bone mineral density
modifications as well as fracture risk later on in life. This is
observed particularly in disabled pediatric patients, in whom
early cardio-vascular and metabolic impairment is already
present due to multisystem dysregulation (20).
We recognize that there are some limitations to this study
starting with the relatively small sample size that was due to
difficulties in enrolling and studying neuro-cognitively disabled
children. Secondly, due to the severity of the clinical condition,
MRI was performed in only one patient with DP. Therefore,
the presence of hypothalamic-pituitary malformations cannot
be excluded in the other patients. Additionally, we considered
a cohort of children with a high grade of disability that can
be implicated in severe biological dysregulation influencing
pubertal progression. A comparison with a group with moderate
disabilities would be useful in future studies. Finally, long-term
anticonvulsant drugs may be associated with sexual maturation
disorders; all of the patients received polytherapy and the effects
of single anticonvulsants were not pondered, however since
all the subjects were on anticonvulsant medications this can
be considered a systematic error. Despite the acknowledged
limitations, which do not allow generalizations, the present
report highlights that NI children and adolescents also experience
delayed pubertal changes. Further research is recommended
to establish whether DP is a primary manifestation or
a secondary consequence of chronic impaired health
and malnutrition.
In conclusion, NI children and adolescents may experience
delayed pubertal changes. Once accessed the care process all
patients should undergo an endocrinological assessment and
Frontiers in Pediatrics | www.frontiersin.org 3 November 2019 | Volume 7 | Article 462
Calcaterra et al. Delayed Puberty in Disabled Children
subsequently evaluated twice a year to detect precocious or
delayed pubertal development in order to be cared.
Moreover, an endocrine monitoring should be also required
at least once a year after pubertal development, to evaluate
whether targeted interventions can improve outcomes, as
well as reassessed form a nutritional point of view to
offer tailored nutritional interventions and limit malnutrition
comorbidities (21, 22).
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